Infection Due to Serratia sp. in Chronic Granulomatous Disease—Is the Incidence Low in Tropical Countries?

[1]  V. Viswanathan,et al.  Chronic granulomatous disease presenting with foot abscess caused by Serratia marcescens and autoimmune dactylitis , 2020 .

[2]  J. Casanova,et al.  Genetic, Immunological, and Clinical Features of the First Mexican Cohort of Patients with Chronic Granulomatous Disease , 2020, Journal of Clinical Immunology.

[3]  M. El-Mokhtar,et al.  “Clinical Aspects of Chronic Granulomatous Disease in Upper Egypt” , 2020, Immunological investigations.

[4]  Y. Lau,et al.  Clinical and genetic characteristics of Chinese pediatric patients with chronic granulomatous disease , 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[5]  D. Heymann,et al.  Community level antibiotic utilization in India and its comparison vis-à-vis European countries: Evidence from pharmaceutical sales data , 2018, PloS one.

[6]  S. Handunnetti,et al.  Preliminary study on chronic granulomatous disease in Sri Lanka , 2018, Allergy, Asthma & Clinical Immunology.

[7]  G. Şensoy,et al.  Seven chronic granulomatous disease cases in a single-center experience and a review of the literature. , 2018, Asian Pacific journal of allergy and immunology.

[8]  Alicia Montaner Ramón,et al.  Infecciones por Serratia, ¿debemos pensar en mmunodeficienaas primarias? , 2017 .

[9]  O. Ohara,et al.  Infection Profile in Chronic Granulomatous Disease: a 23-Year Experience from a Tertiary Care Center in North India , 2017, Journal of Clinical Immunology.

[10]  C. Guerrero Laleona,et al.  [Serratia infections, should we think about primary immunodeficiencies?] , 2017, Archivos Argentinos de Pediatria.

[11]  M. Barbouche,et al.  A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients , 2016, Journal of Clinical Immunology.

[12]  A. Rawat,et al.  Chronic Granulomatous Disease , 1999, The Indian Journal of Pediatrics.

[13]  S. Holland,et al.  Common severe infections in chronic granulomatous disease. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  I. Majdoub,et al.  Granulomatose septique chronique révélée par une ostéomyélite à Serratia marcescens , 2014 .

[15]  Yi-Tsung Lin,et al.  A multicenter surveillance of antimicrobial resistance in Serratia marcescens in Taiwan , 2013, Journal of Microbiology, Immunology and Infection.

[16]  H. Keskes,et al.  [Serratia marcescens osteomyelitis as the first manifestation of chronic granulomatous disease]. , 2014, Archives de pédiatrie.

[17]  A. Khanna,et al.  Serratia marcescens- a rare opportunistic nosocomial pathogen and measures to limit its spread in hospitalized patients. , 2013, Journal of clinical and diagnostic research : JCDR.

[18]  M. Jemaa,et al.  Metacarpal osteomyelitis and chronic granulomatous disease. , 2013, The Pediatric Infectious Disease Journal.

[19]  Steven D. Mahlen.  Serratia Infections: from Military Experiments to Current Practice , 2011, Clinical Microbiology Reviews.

[20]  M. Moin,et al.  Inheritance Pattern and Clinical Aspects of 93 Iranian Patients with Chronic Granulomatous Disease , 2011, Journal of Clinical Immunology.

[21]  J. Horng,et al.  RssAB-FlhDC-ShlBA as a Major Pathogenesis Pathway in Serratia marcescens , 2010, Infection and Immunity.

[22]  Ronald N. Jones.  Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  Dirk Roos,et al.  Chronic Granulomatous Disease: The European Experience , 2009, PloS one.

[24]  R. Gavrieli,et al.  Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. , 2008, Clinical immunology.

[25]  L. Notarangelo,et al.  Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. , 2008, Clinical immunology.

[26]  P. Williams,et al.  The RssAB Two-Component Signal Transduction System in Serratia marcescens Regulates Swarming Motility and Cell Envelope Architecture in Response to Exogenous Saturated Fatty Acids , 2005, Journal of bacteriology.

[27]  T. Matsuyama,et al.  Temperature-Dependent Bacteriostatic Activity of Serratia marcescens , 2004 .

[28]  S. Holland,et al.  Reinfection, rather than persistent infection, in patients with chronic granulomatous disease. , 2003, The Journal of infectious diseases.

[29]  S. Orkin,et al.  Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. , 1990, The Journal of clinical investigation.

[30]  S. Klebanoff,et al.  Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood. , 1969, The New England journal of medicine.